Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;30(1):5-7.
doi: 10.1089/aid.2013.1503.

AIDS: The final chapter?

Mathilde Krim  1 , Rowena Johnston
Affiliations

AIDS: The final chapter?

Mathilde Krim et al. AIDS Res Hum Retroviruses. 2014 Jan.
No abstract available

PubMed Disclaimer

References

    1. De Clercq E: HIV inhibitors targeted at the reverse transcriptase. AIDS Res Hum Retroviruses 1992;8(2):119–134 - PubMed
    1. Debouck C: The HIV protease as a therapeutic target for AIDS. AIDS Res Hum Retroviruses 1992;8(2):153–164 - PubMed
    1. Wild C, Greenwell T, and Matthew T: A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res Hum Retroviruses 1993;9(11):1051–1053 - PubMed
    1. Young B, Squires KE, Ross LL, Santiago L, Sloan LM, Zhao HH, Wine BC, Pakes GE, Margolis DA, Shaefer MS, and the Aries EPZ108859 Study Team: Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES. AIDS Res Hum Retroviruses 2013;29(2):350–358 - PMC - PubMed
    1. Jansen K, Sönnerborg A, Brockmeyer N, Thalme A, Svedhem V, Dupke S, Eychenne JL, Nakonz T, Jimenez-Exposito MJ, and Pugliese P: Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced patients with HIV type 1 infection. AIDS Res Hum Retroviruses 2013;29(3):564–573 - PMC - PubMed

LinkOut - more resources